Advanced Health Intelligence Ltd (ASX:AHI; NASDAQ:AHI) has released its unaudited Preliminary Final Report for the year ended 30 June 2024. The report highlights the company's significant fall in net loss after tax of 68.4% compared to the previous year, along with key developments in gaining control over Vertica Health Pty Ltd and Wellteq Digital Health Inc group.
Advanced Health Intelligence Ltd (AHI) is committed to becoming a global leader in digital health, leveraging its proprietary technology to redefine health screening. AHI aims to improve healthcare outcomes, enhance health literacy, and support the early detection and management of various health conditions. The company's suite of solutions includes body dimension and composition assessments, blood biomarker prediction, transdermal optical imaging, dermatological skin identification, and personalized health coaching. AHI's vision extends beyond individual health assessments to create a transformative impact at scale, driving forward a new era in digital healthcare.
AHI's preliminary final report for FY24 showcases a 68.4% fall in net loss after tax, reflecting a reduction in the consolidated entity's cost base and an improvement in the fair value of its material investments. The company is currently raising capital and expects a material uplift in operating revenue as its commercial partners begin to utilize its suite of products. AHI's commitment to digital health innovation, including the development of the Biometric Health Assessment and expansion into dermatological AI platforms, demonstrates its dedication to revolutionizing patient care and enhancing healthcare outcomes. Despite challenges with its Nasdaq listing, AHI remains focused on expanding its partner base and technology offering to drive global impact in the digital healthcare space.